ALOT Stock Analysis: AstroNova | NASDAQ
Computer Hardware | NASDAQ, USA | Market Cap: 221m USD | 12M Return: 148.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.70M
Rev. Trend: 47.9%
Warnings
Tailwinds
Seasonality 11.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
AstroNova, Inc. (NASDAQ: ALOT) designs, manufactures, and distributes specialty printers and data acquisition systems, operating across two core business lines. Its Product Identification segment produces color label printers, direct-to-package printers, high-volume presses, and related consumables (ink, toner, thermal transfer ribbons) under the QuickLabel, TrojanLabel, GetLabels, Astro Machine, and MTEX brands. Its Test & Measurement segment supplies airborne printers (ToughWriter series) for military and commercial flight decks, ethernet switches (ToughSwitch), and high-speed data acquisition systems (TMX, Daxus, SmartCorder, Everest) for aerospace and defense applications, along with on-site service, training, and software licensing for label design and printer management. The company sells globally, with primary markets in the United States, Europe, Canada, Asia, and Central and South America.
Founded in 1969 and headquartered in West Warwick, Rhode Island, AstroNova rebranded from Astro-Med, Inc. in May 2016. The company sits within the Information Technology sector (GICS sub-industry: Technology Hardware, Storage & Peripherals) and is classified as a micro-cap stock with a market capitalization of roughly $221 million, reflecting its position as a niche, diversified specialty hardware supplier rather than a high-volume commodity manufacturer.
- ToughWriter aerospace printer orders drive defense segment growth
- Label printer demand recovers as packaging and e-commerce volumes rebound
- Supply chain costs and product mix pressure gross margins
| Net Income: -1.35m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 6.13 > 1.0 |
| NWC/Revenue: 21.22% < 20% (prev 20.85%; Δ 0.37% < -1%) |
| CFO/TA 0.07 > 3% & CFO 10.4m > Net Income -1.35m |
| Net Debt (34.8m) to EBITDA (6.49m): 5.36 < 3 |
| Current Ratio: 1.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.77m) vs 12m ago 2.83% < -2% |
| Gross Margin: 33.90% > 18% (prev 34.24%; Δ -0.35% > 0.5%) |
| Asset Turnover: 104.9% > 50% (prev 103.8%; Δ 1.08% > 0%) |
| Interest Coverage Ratio: 0.55 > 6 (EBIT TTM 1.80m / Interest Expense TTM 3.28m) |
| A: 0.23 (Total Current Assets 74.7m - Total Current Liabilities 42.4m) / Total Assets 139.9m |
| B: 0.34 (Retained Earnings 47.7m / Total Assets 139.9m) |
| C: 0.01 (EBIT TTM 1.80m / Avg Total Assets 145.1m) |
| D: 1.25 (Book Value of Equity 77.5m / Total Liabilities 62.2m) |
| Altman-Z'' = 4.02 = AA |
| DSRI: 1.04 (Receivables 21.6m/21.4m, Revenue 152.2m/156.0m) |
| GMI: 1.01 (GM 34.24% / 33.90%) |
| AQI: 1.08 (AQ_t 0.35 / AQ_t-1 0.33) |
| SGI: 0.98 (Revenue 152.2m / 156.0m) |
| TATA: -0.08 (NI -1.35m - CFO 10.4m) / TA 139.9m) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 28.52 with a total of 130,229 shares traded. Over the past week, the price has changed by +0.04%, over one month by +79.15%, over three months by +146.50% and over the past year by +148.87%.
Current recommended Stop Loss: 27.90 (which is 2.2% or 1 ATR below the current price).
AstroNova has no consensus analysts rating.
| Analysts Target Price | 26 | -8.8% |
P/E Forward = 13.9665
P/S = 1.4555
P/B = 2.857
Revenue TTM = 152.2m USD
EBIT TTM = 1.80m USD
EBITDA TTM = 6.49m USD
Long Term Debt = 16.2m USD (from longTermDebt, last quarter)
Short Term Debt = 19.7m USD (from shortTermDebt, last quarter)
Debt = 39.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 1.78m
Net Debt = 34.8m USD (calculated: Debt 39.5m - CCE 4.67m)
Enterprise Value = 256.3m USD (221.5m + Debt 39.5m - CCE 4.67m)
Interest Coverage Ratio = 0.55 (Ebit TTM 1.80m / Interest Expense TTM 3.28m)
EV/FCF = 25.47x (Enterprise Value 256.3m / FCF TTM 10.1m)
FCF Yield = 3.93% (FCF TTM 10.1m / Enterprise Value 256.3m)
FCF Margin = 6.61% (FCF TTM 10.1m / Revenue TTM 152.2m)
Net Margin = -0.88% (Net Income TTM -1.35m / Revenue TTM 152.2m)
Gross Margin = 33.90% ((Revenue TTM 152.2m - Cost of Revenue TTM 100.6m) / Revenue TTM)
Gross Margin QoQ = 36.65% (prev 30.17%)
Tobins Q-Ratio = 1.83 (Enterprise Value 256.3m / Total Assets 139.9m)
Interest Expense / Debt = 8.31% (Interest Expense 3.28m / Debt 39.5m)
Taxrate = 23.09% (196k / 849k)
NOPAT = 1.38m (EBIT 1.80m * (1 - 23.09%))
Current Ratio = 1.76 (Total Current Assets 74.7m / Total Current Liabilities 42.4m)
Debt / Equity = 0.51 (Debt 39.5m / totalStockholderEquity, last quarter 77.5m)
Debt / EBITDA = 5.36 (Net Debt 34.8m / EBITDA 6.49m)
Debt / FCF = 3.46 (Net Debt 34.8m / FCF TTM 10.1m)
Total Stockholder Equity = 76.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.93% (Net Income -1.35m / Total Assets 139.9m)
RoE = -1.75% (Net Income TTM -1.35m / Total Stockholder Equity 76.8m)
RoCE = 1.93% (EBIT 1.80m / Capital Employed (Equity 76.8m + L.T.Debt 16.2m))
RoIC = 1.23% (NOPAT 1.38m / Invested Capital 112.5m)
WACC = 11.24% (E(221.5m)/V(261.0m) * Re(12.10%) + D(39.5m)/V(261.0m) * Rd(8.31%) * (1-Tc(0.23)))
Discount Rate = 12.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 51.11 | Cagr: 1.31%
[DCF] Terminal Value 69.22% ; FCFF base≈6.68m ; Y1≈7.66m ; Y5≈11.3m
[DCF] Fair Price = 9.96 (EV 112.2m - Net Debt 34.8m = Equity 77.4m / Shares 7.77m; r=11.24% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 47.86 | Revenue CAGR: 0.94% | SUE: N/A | # QB: 0